Summary
- Current Price
- As of today, ENLV price is $0.90, down -14.29% on
- Current Price All-Time High
- ENLV price is currently -99.80% below its historical high of $440.00 set on
- Market Cap
- ENLV current market cap is $214M, up +823.49% over the past 365 days
- PE Ratio
- ENLV current PE ratio is 0.04
- Revenue
- ENLV current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for ENLV has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Enlivex Therapeutics Ltd. |
| Ticker | NASDAQ: ENLV |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Israel |
| IPO | |
| Indexes | Not included |
| Website | enlivex.com |
| Employees | 71 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.90 | ||
| Price, 1D Change | -14.29% | |
| $214M | ||
| - | ||
| 0.04 | ||
| 0.79 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| $25.48 | ||
| EPS, 1Y Change | +3,580.72% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:8 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ORPN | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $25.48 | ||
| EPS Estimate | N/A | -$0.32 |
| EPS Est. Change | N/A | -101.26% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $0.90 | ||
| Price Target | - | $13.00 |
| Price Tgt. Change | - | +1,344.44% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.65 | -$0.73 | -12.60% | |
| -$0.40 | $25.48 | +6,549.47% | |
| -$0.32 | N/A | -101.26% | |
| -$0.78 | N/A | -103.06% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -7.22% | ||
| -75.27% | ||
| +823.49% | ||
| +216.13% | ||
| 0.00% | ||
| 0.00% | ||
| +3,580.72% | ||
| +1,608.76% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.90 | ||
| $1.09 | ||
| SMA 200 vs Price | +20.61% | |
| $1.10 | ||
| SMA 50 vs Price | +21.76% | |
| 0.79 | ||
| $0.09 | ||
| 36.45 | ||
| 115.26% | ||
| 77.80% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| $25.48 | ||
| -$332.00K | ||
| - | ||
| -$15.00M | ||
| - | ||
| $1.24B | ||
| - | ||
| -$14.67M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 193.24 | ||
| 193.24 | ||
| - | ||
| - | ||
| 1.87 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 0.04 | ||
| - | ||
| 0.11 | ||
| -14.21 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.93B | ||
| $5.87M | ||
| $2.33B | ||
| $1.74B | ||
| $392.05M | ||
| $9.02M | ||
| $641.00K | ||
| $258.00K | ||
| $3.81M |
Expenses
| Metric | Date | Value |
|---|---|---|
| -$1.24B | ||
| $14.67M | ||
| $332.00K | ||
| $0.00 | ||
| $332.00K | ||
| $0.00 | ||
| $382.65M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$10.42M | ||
| -$1.32M | ||
| $10.38M | ||
| $19.57M | ||
| -$29.98M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| HC Wainwright & Co. | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with ENLV
FAQ
What is the ticker symbol for Enlivex Therapeutics Ltd.?
The ticker symbol for Enlivex Therapeutics Ltd. is NASDAQ:ENLV
Does Enlivex Therapeutics Ltd. pay dividends?
No, Enlivex Therapeutics Ltd. does not pay dividends
What sector is Enlivex Therapeutics Ltd. in?
Enlivex Therapeutics Ltd. is in the Healthcare sector
What industry is Enlivex Therapeutics Ltd. in?
Enlivex Therapeutics Ltd. is in the Biotechnology industry
What country is Enlivex Therapeutics Ltd. based in?
Enlivex Therapeutics Ltd. is headquartered in Israel
When did Enlivex Therapeutics Ltd. go public?
Enlivex Therapeutics Ltd. initial public offering (IPO) was on July 31, 2014
Is Enlivex Therapeutics Ltd. in the S&P 500?
No, Enlivex Therapeutics Ltd. is not included in the S&P 500 index
Is Enlivex Therapeutics Ltd. in the NASDAQ 100?
No, Enlivex Therapeutics Ltd. is not included in the NASDAQ 100 index
Is Enlivex Therapeutics Ltd. in the Dow Jones?
No, Enlivex Therapeutics Ltd. is not included in the Dow Jones index
When was Enlivex Therapeutics Ltd. last earnings report?
Enlivex Therapeutics Ltd.'s most recent earnings report was on November 18, 2022
When does Enlivex Therapeutics Ltd. report earnings?
The date for Enlivex Therapeutics Ltd.'s next earnings report has not been announced yet
Data Sources & References
- ENLV Official Website www.enlivex.com
- ENLV Profile on Yahoo Finance finance.yahoo.com/quote/ENLV
- ENLV Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/enlv